NO305249B1 - Imidazopyridinforbindelser, farmas°ytiske preparater som inneholder minst Ún slik forbindelse, og anvendelse av forbindelsene til fremstilling av legemidler - Google Patents

Imidazopyridinforbindelser, farmas°ytiske preparater som inneholder minst Ún slik forbindelse, og anvendelse av forbindelsene til fremstilling av legemidler

Info

Publication number: NO305249B1
Authority: NO; Norway
Prior art keywords: opt; het2; cooa; substd; cyc
Prior art date: 1994-09-15

Application number

NO953624A

Other languages

English (en)

Norwegian (no)

Other versions

NO953624L (no

NO953624D0 (no

Inventor

Werner Mederski

Dieter Dorsch

Mathias Osswald

Pierre Schelling

Norbert Beier

Klaus-Otto Minck

Ingeborg Lues

Original Assignee

Merck Patent Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-09-15

Filing date

1995-09-14

Publication date

1999-04-26

1995-09-14 Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh

1995-09-14 Publication of NO953624D0 publication Critical patent/NO953624D0/no

1996-03-18 Publication of NO953624L publication Critical patent/NO953624L/no

1999-04-26 Publication of NO305249B1 publication Critical patent/NO305249B1/no

Links

150000001875 compounds Chemical class 0.000 title 2
239000003814 drug Substances 0.000 title 1
125000004857 imidazopyridinyl group Chemical class N1C(=NC2=C1C=CC=N2)* 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1
239000000825 pharmaceutical preparation Substances 0.000 title 1
-1 1H-5-tetrazolyl Chemical group 0.000 abstract 4
125000003342 alkenyl group Chemical group 0.000 abstract 4
125000000304 alkynyl group Chemical group 0.000 abstract 4
125000000896 monocarboxylic acid group Chemical group 0.000 abstract 4
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 abstract 3
125000000217 alkyl group Chemical group 0.000 abstract 3
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 2
CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical compound O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 abstract 2
GAMYYCRTACQSBR-UHFFFAOYSA-N 4-azabenzimidazole Chemical compound C1=CC=C2NC=NC2=N1 GAMYYCRTACQSBR-UHFFFAOYSA-N 0.000 abstract 1
101100134927 Gallus gallus COR8 gene Proteins 0.000 abstract 1
DBTDEFJAFBUGPP-UHFFFAOYSA-N Methanethial Chemical compound S=C DBTDEFJAFBUGPP-UHFFFAOYSA-N 0.000 abstract 1
125000002947 alkylene group Chemical group 0.000 abstract 1
125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
125000000753 cycloalkyl group Chemical group 0.000 abstract 1
125000001072 heteroaryl group Chemical group 0.000 abstract 1
125000000623 heterocyclic group Chemical group 0.000 abstract 1
125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Psychiatry (AREA)
Urology & Nephrology (AREA)
Dermatology (AREA)
Pain & Pain Management (AREA)
Ophthalmology & Optometry (AREA)
Anesthesiology (AREA)
Hospice & Palliative Care (AREA)
Vascular Medicine (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)

NO953624A 1994-09-15 1995-09-14 Imidazopyridinforbindelser, farmas°ytiske preparater som inneholder minst Ún slik forbindelse, og anvendelse av forbindelsene til fremstilling av legemidler NO305249B1 (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE4432860A DE4432860A1 (de)	1994-09-15	1994-09-15	Imidazopyridine

Publications (3)

Publication Number	Publication Date
NO953624D0 NO953624D0 (no)	1995-09-14
NO953624L NO953624L (no)	1996-03-18
NO305249B1 true NO305249B1 (no)	1999-04-26

Family

ID=6528291

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO953624A NO305249B1 (no)	1994-09-15	1995-09-14	Imidazopyridinforbindelser, farmas°ytiske preparater som inneholder minst Ún slik forbindelse, og anvendelse av forbindelsene til fremstilling av legemidler

Country Status (22)

Country	Link
US (1)	US5684015A (fr)
EP (1)	EP0702013B1 (fr)
JP (1)	JPH0881466A (fr)
KR (1)	KR100373972B1 (fr)
CN (1)	CN1046942C (fr)
AT (1)	ATE202104T1 (fr)
AU (1)	AU702722B2 (fr)
CA (1)	CA2158225A1 (fr)
CZ (1)	CZ286739B6 (fr)
DE (2)	DE4432860A1 (fr)
DK (1)	DK0702013T3 (fr)
ES (1)	ES2159589T3 (fr)
GR (1)	GR3036339T3 (fr)
HU (1)	HU220042B (fr)
NO (1)	NO305249B1 (fr)
PL (1)	PL310460A1 (fr)
PT (1)	PT702013E (fr)
RU (1)	RU2156251C2 (fr)
SK (1)	SK282116B6 (fr)
TW (1)	TW323280B (fr)
UA (1)	UA41358C2 (fr)
ZA (1)	ZA957754B (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19845153A1 (de) *	1998-10-01	2000-04-06	Merck Patent Gmbh	Imidazo[4,5]-pyridin-4-on-derivate
EP1013273A1 (fr) *	1998-12-23	2000-06-28	Novartis AG	Utilisation des antagonistes du recepteur AT-1 ou des modulateurs du recepteur AT-2 pour le traitement de maladies asocciées à une augmentation de recepteurs AT-1 ou AT-2
US6465502B1 (en)	1998-12-23	2002-10-15	Novartis Ag	Additional therapeutic use
KR100646716B1 (ko) *	1998-12-23	2006-11-17	노파르티스 아게	Ａｔ-1 또는 ａｔ-2 수용체의 증가와 관련된 질환의치료에 있어서 ａｔ-1 수용체 길항제 또는 ａｔ-2 수용체조절제의 용도
EP1714651A1 (fr) *	1999-01-26	2006-10-25	Novartis AG	Utilisation des antagonistes du recepteur de l' angiotensine II pour le traitement de l' infractus du myocarde aigu
CN101011390A (zh)	1999-01-26	2007-08-08	诺瓦提斯公司	血管紧张素ⅱ受体拮抗剂在治疗急性心肌梗塞中的应用
US6514989B1 (en) *	2001-07-20	2003-02-04	Hoffmann-La Roche Inc.	Aromatic and heteroaromatic substituted 1,2,4-triazolo pyridine derivatives
AR037097A1 (es) *	2001-10-05	2004-10-20	Novartis Ag	Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento
AU2003300360A1 (en) *	2002-12-20	2004-07-22	Migenix Corp.	Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto
JP2006511587A (ja) *	2002-12-20	2006-04-06	ミジェニックスコーポレイション	アデニンヌクレオチドトランスロカーゼ（ａｎｔ）リガンドならびにそれに関連する組成物および方法
CA2518465A1 (fr)	2003-03-25	2004-10-14	Takeda San Diego, Inc.	Inhibiteurs de dipeptidyle peptidase
US7638638B2 (en)	2003-05-14	2009-12-29	Takeda San Diego, Inc.	Dipeptidyl peptidase inhibitors
US7169926B1 (en)	2003-08-13	2007-01-30	Takeda Pharmaceutical Company Limited	Dipeptidyl peptidase inhibitors
KR20060041309A (ko)	2003-08-13	2006-05-11	다케다 야쿠힌 고교 가부시키가이샤	４-피리미돈 유도체 및 펩티딜 펩티다제 저해제로서의 그의용도
US7678909B1 (en)	2003-08-13	2010-03-16	Takeda Pharmaceutical Company Limited	Dipeptidyl peptidase inhibitors
JP2007505121A (ja)	2003-09-08	2007-03-08	武田薬品工業株式会社	ジペプチジルぺプチダーゼ阻害剤
AU2004293078B2 (en) *	2003-11-25	2012-01-19	3M Innovative Properties Company	Substituted imidazo ring systems and methods
US7732446B1 (en)	2004-03-11	2010-06-08	Takeda Pharmaceutical Company Limited	Dipeptidyl peptidase inhibitors
EA013427B1 (ru)	2004-03-15	2010-04-30	Такеда Фармасьютикал Компани Лимитед	Ингибиторы дипептидилпептидазы
JP2008501714A (ja)	2004-06-04	2008-01-24	武田薬品工業株式会社	ジペプチジルペプチダーゼインヒビター
WO2006019965A2 (fr)	2004-07-16	2006-02-23	Takeda San Diego, Inc.	Inhibiteurs de la dipeptidyl peptidase
EP1828192B1 (fr)	2004-12-21	2014-12-03	Takeda Pharmaceutical Company Limited	Inhibiteurs de dipeptidyle peptidase
AU2006290205B2 (en)	2005-09-14	2012-12-13	Takeda Pharmaceutical Company Limited	Dipeptidyl peptidase inhibitors for treating diabetes
CA2622642C (fr)	2005-09-16	2013-12-31	Takeda Pharmaceutical Company Limited	Inhibiteurs de dipeptidylpeptidase
WO2007112347A1 (fr)	2006-03-28	2007-10-04	Takeda Pharmaceutical Company Limited	Inhibiteurs de la dipeptidyl peptidase
US8324383B2 (en)	2006-09-13	2012-12-04	Takeda Pharmaceutical Company Limited	Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile
TW200838536A (en)	2006-11-29	2008-10-01	Takeda Pharmaceutical	Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
US8093236B2 (en)	2007-03-13	2012-01-10	Takeda Pharmaceuticals Company Limited	Weekly administration of dipeptidyl peptidase inhibitors
EP2321011A1 (fr) *	2008-06-25	2011-05-18	Pfizer Inc.	Composés diaryle et leurs utilisations
GB201321735D0 (en)	2013-12-09	2014-01-22	Ucb Pharma Sa	Therapeutic Agents
WO2017184765A1 (fr) *	2016-04-21	2017-10-26	MediSynergics, LLC	Composés à base de récepteur opiacé kappa et procédés d'utilisation

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5036048A (en)	1986-03-07	1991-07-30	Schering Corporation	Angiotensin II receptor blockers as antiglaucoma agents
US4880804A (en)	1988-01-07	1989-11-14	E. I. Du Pont De Nemours And Company	Angiotensin II receptor blocking benzimidazoles
IL94390A (en) *	1989-05-30	1996-03-31	Merck & Co Inc	The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them
US5332744A (en) *	1989-05-30	1994-07-26	Merck & Co., Inc.	Substituted imidazo-fused 6-membered heterocycles as angiotensin II antagonists
EP0430709A3 (en)	1989-12-01	1992-02-12	Glaxo Group Limited	Benzthiophen derivatives
US5140037A (en)	1990-03-20	1992-08-18	E. I. Du Pont De Nemours And Company	Treatment of central nervous system disorders with imidazole angiotensin-ii receptor antagonists
EP0503838A3 (en) *	1991-03-08	1992-10-07	Merck & Co. Inc.	Heterocyclic compounds bearing acidic functional groups as angiotensin ii antagonists
DE4110019C2 (de) *	1991-03-27	2000-04-13	Merck Patent Gmbh	Imidazopyridine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
CA2109524A1 (fr) *	1991-05-10	1992-11-11	Prasun K. Chakravarty	Derives acides d'aralkyltriazole, antagonistes de l'angiotensine ii
US5238942A (en) *	1991-05-10	1993-08-24	Merck & Co., Inc.	Substituted quinazolinones bearing acidic functional groups as angiotensin ii antagonists
JPH06510763A (ja) *	1991-08-19	1994-12-01	イー・アイ・デュポン・ドゥ・ヌムール・アンド・カンパニー	アンジオテンシン２受容体遮断イミダゾリノン誘導体
EP0531874A1 (fr) *	1991-09-10	1993-03-17	Tanabe Seiyaku Co., Ltd.	Dérivés d'imidazopyridine et procédé de préparation
DE4141788A1 (de) *	1991-12-18	1993-06-24	Merck Patent Gmbh	Imidazopyridine
DE4305602A1 (de) *	1992-06-17	1993-12-23	Merck Patent Gmbh	Imidazopyridine
DE4225835A1 (de) *	1992-08-05	1994-02-10	Merck Patent Gmbh	Verfahren zur Herstellung von Imidazopyridinen
DE4236026A1 (de) *	1992-10-24	1994-04-28	Merck Patent Gmbh	Imidazopyridine
DE4242459A1 (de) *	1992-12-16	1994-06-23	Merck Patent Gmbh	Imidazopyridine
US5262412A (en) *	1993-03-10	1993-11-16	Merck & Co., Inc.	Substituted pyrazoles, compositions and use
DE4318813A1 (de) *	1993-06-07	1994-12-08	Merck Patent Gmbh	Imidazopyridine
US5395844A (en) *	1993-06-10	1995-03-07	The Du Pont Merck Pharmaceutical Company	Imidazole 5-position substituted angiotensin II antagonists
ES2105939B1 (es) *	1994-08-02	1998-07-01	Uriach & Cia Sa J	Nuevos pirazoles con actividad antagonista de la angiotensina ii.

1994
- 1994-09-15 DE DE4432860A patent/DE4432860A1/de not_active Withdrawn
1995
- 1995-08-16 TW TW084108552A patent/TW323280B/zh active
- 1995-09-04 AT AT95113840T patent/ATE202104T1/de not_active IP Right Cessation
- 1995-09-04 ES ES95113840T patent/ES2159589T3/es not_active Expired - Lifetime
- 1995-09-04 EP EP95113840A patent/EP0702013B1/fr not_active Expired - Lifetime
- 1995-09-04 DK DK95113840T patent/DK0702013T3/da active
- 1995-09-04 PT PT95113840T patent/PT702013E/pt unknown
- 1995-09-04 DE DE59509331T patent/DE59509331D1/de not_active Expired - Fee Related
- 1995-09-08 AU AU31715/95A patent/AU702722B2/en not_active Ceased
- 1995-09-11 SK SK1123-95A patent/SK282116B6/sk unknown
- 1995-09-13 CN CN95116867A patent/CN1046942C/zh not_active Expired - Fee Related
- 1995-09-13 CZ CZ19952362A patent/CZ286739B6/cs not_active IP Right Cessation
- 1995-09-13 CA CA002158225A patent/CA2158225A1/fr not_active Abandoned
- 1995-09-14 JP JP7260957A patent/JPH0881466A/ja active Pending
- 1995-09-14 HU HU9502688A patent/HU220042B/hu not_active IP Right Cessation
- 1995-09-14 US US08/528,305 patent/US5684015A/en not_active Expired - Fee Related
- 1995-09-14 ZA ZA957754A patent/ZA957754B/xx unknown
- 1995-09-14 PL PL95310460A patent/PL310460A1/xx unknown
- 1995-09-14 UA UA95094165A patent/UA41358C2/uk unknown
- 1995-09-14 KR KR1019950029948A patent/KR100373972B1/ko not_active Expired - Fee Related
- 1995-09-14 RU RU95115970/04A patent/RU2156251C2/ru not_active IP Right Cessation
- 1995-09-14 NO NO953624A patent/NO305249B1/no unknown
2001
- 2001-08-07 GR GR20010401191T patent/GR3036339T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
KR100373972B1 (ko)	2003-06-02
US5684015A (en)	1997-11-04
AU3171595A (en)	1996-03-28
EP0702013A2 (fr)	1996-03-20
GR3036339T3 (en)	2001-11-30
NO953624L (no)	1996-03-18
NO953624D0 (no)	1995-09-14
EP0702013B1 (fr)	2001-06-13
JPH0881466A (ja)	1996-03-26
UA41358C2 (uk)	2001-09-17
AU702722B2 (en)	1999-03-04
EP0702013A3 (fr)	1996-05-08
KR960010639A (ko)	1996-04-20
SK282116B6 (sk)	2001-11-06
TW323280B (fr)	1997-12-21
ATE202104T1 (de)	2001-06-15
SK112395A3 (en)	1997-06-04
HU9502688D0 (en)	1995-11-28
DE4432860A1 (de)	1996-03-21
CN1129702A (zh)	1996-08-28
CN1046942C (zh)	1999-12-01
HU220042B (hu)	2001-10-28
ZA957754B (en)	1996-04-09
PL310460A1 (en)	1996-03-18
DK0702013T3 (da)	2001-09-03
CZ286739B6 (en)	2000-06-14
RU2156251C2 (ru)	2000-09-20
PT702013E (pt)	2001-10-30
DE59509331D1 (de)	2001-07-19
CA2158225A1 (fr)	1996-03-16
CZ236295A3 (en)	1996-04-17
ES2159589T3 (es)	2001-10-16
HUT74939A (en)	1997-03-28

Publication	Publication Date	Title
PL310460A1 (en)	1996-03-18	Novel derivatives of imidazopyridine, method of obtaining them and drugs containing such derivatives
HUT73240A (en)	1996-07-29	Cycloalkano-indol- and -azaindol derivatives and pharmaceutical compositions containing the same
FI955140A0 (fi)	1995-10-27	Uusia kinoksaliinidionijohdannaisia, niiden valmistus ja käyttö lääkkeissä
DK0585155T3 (da)	1997-06-09	Trifluormethylketon-peptidderivater med HLE-inhiberende aktivitet, deres fremstilling og farmaceutiske præparater
ES2052387T3 (es)	1994-07-01	Utilizacion de derivados de pirimidina-3-oxido para frenar la caida de los cabellos y composiciones topicas empleadas.
NO305835B1 (no)	1999-08-02	Aralkyltiadiazinonderivater, farmas°ytiske preparater som inneholder minst Ún slik forbindelse, samt anvendelse av forbindelsene til fremstilling av legemidler
SE8303987D0 (sv)	1983-07-14	N-phenylpyrazole derivatives useful as herbicides
IL119054A0 (en)	1996-11-14	Substituted 4H-pyrans their preparation and pharmaceutical compositions containing them
FI955670A0 (fi)	1995-11-24	2-aminobentseenisulfonihappo- ja 2-aminobentseenisulfonyyli kloridijohdannaiset, niiden valmistus ja käyttö synteesin välituotteina